"Our practice specializes in the diagnosis and treatment of blood diseases (both malignant and benign) and cancer for patients 16 years and older. Our philosophy is that the most important aspect in the management of patients in our specialty involves advances, advocacy, and availability."

During the past decade, Associates In Hematology Oncology PC-Upland conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 18 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associates In Hematology Oncology PC-Upland" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "Telik" with 2 trials sponsored and "Tragara Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associates In Hematology Oncology PC-Upland" #1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Associates In Hematology Oncology PC-Upland" are "Breast Cancer" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials), "HER2/Neu Positive" (2 trials) and "Ovarian Neoplasms" (2 trials). Many other conditions were trialed in "Associates In Hematology Oncology PC-Upland" in a lesser frequency.

Most popular intervention types in "Associates In Hematology Oncology PC-Upland" are "Drug" (25 trials), "Other" (15 trials), "Biological" (14 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Bevacizumab" (8 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Associates In Hematology Oncology PC-Upland" are 14 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Associates In Hematology Oncology PC-Upland". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Associates In Hematology Oncology PC-Upland, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Associates In Hematology Oncology PC-Upland, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".